相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human Granzyme K protein
- 形态:
liquid
- 克隆性:
单克隆
- 保质期:
见COA
- 库存:
大量
- 供应商:
北京辰辉创聚生物技术有限公司
- 应用范围:
ELISA, IF, WB
- 靶点:
Granzyme K
- 抗体英文名:
Anti-Granzyme K Monoclonal Antibody
- 抗体名:
抗Granzyme K单抗
- 规格:
100ul; 500ul; 1ml

| 产品信息
品名:NebuSelect™ Anti-Granzyme K Monoclonal Antibody
别名:GZMK, TRYP2, Granzyme K, Fragmentin-3, Granzyme-3, NK-tryptase-2, NK-Tryp-2
货号:NBAB-191839
品牌:Nebulabio
规格:100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-Granzyme K Monoclonal Antibody (Cat# NBAB-191839) was produced in rabbits immunized with recombinant Human Granzyme K protein, and it reacts with Human. This antibody is validated for ELISA, IF, WB.
| 产品属性
Product Category:Rabbit MAb
Reactivity:Human
Specificity:Human Granzyme K
Immunogen:Recombinant Human Granzyme K protein
Isotype:Monoclonal Rabbit IgG
Purification:Protein A & Protein G Affinity Purification
Buffer:0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate:Unconjugated
Applications:ELISA, IF, WB
Dilution:ELISA 1:2000~1:10000; IF 1:50~1:500; WB: 1:1000~1:5000
Storage:This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Murine Monoclonal Antibody Development
Major advances in the analysis of biomolecular structure have emerged from the development of highly specific monoclonal antibodies (MAb) by K�hler and Milstein in 1975 (1 ). MAb are produced from hybridoma cell lines that secrete a single
Technology and Production of Murine Monoclonal and Recombinant Antibodies and Antibody Fragments
production described by K�hler and Milstein in 1975 (1 ). In the last 30 yr a number of genetically engineered antibody constructions have emerged, including chimeric and human-like antibodies as well as different antibody fragments. Nowadays, 18 rnAb
Generation of Antibody Molecules Through Antibody Engineering
Twenty-five years ago, Georges K�hler and C�sar Milstein invented a means of cloning individual antibodies, thus opening up the way for tremendous advances in the fields of cell biology and clinical diagnostics ( 1 ). However, in spite
技术资料暂无技术资料 索取技术资料









